JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deeb, S. S.
Right arrow Articles by Knopp, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deeb, S. S.
Right arrow Articles by Knopp, R. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 266, Issue 21, 13654-13660, 07, 1991

A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins

SS Deeb, MC Cheung, RL Peng, AC Wolf, R Stern, JJ Albers and RH Knopp
Department of Medicine, University of Washington School of Medicine, Seattle.

Epidemiologic and genetic data suggest an inverse relationship between plasma high density lipoprotein (HDL) cholesterol and the incidence of premature coronary artery disease. Some of the defects leading to low levels of HDL may be a consequence of mutations in the genes coding for HDL apolipoproteins A-I and A-II or for enzymes that modify these particles. A proband with plasma apoA-I and HDL cholesterol that are below 15% of normal levels and with marked bilateral arcus senilis was shown to be heterozygous for a 45-base pair deletion in exon four of the apoA-I gene. This most likely represents a de novo mutation since neither parent carries the mutant allele. The protein product of this allele is predicted to be missing 15 (Glu146-Arg160) of the 22 amino acids comprising the third amphipathic helical domain. The HDL of the proband and his family were studied. Using anti-A-I and anti-A-II immunosorbents we found three populations of HDL particles in the proband. One contained both apoA-I and A-II, Lp(A-I w A-II); one contained apoA-I but no A-II, Lp(A-I w/o A-II); and the third (an unusual one) contained apoA-II but no A-I. Only Lp(A-I w A-II) and (A-I w/o A-II) were present in the plasma of the proband's parents and brother. Analysis of the HDL particles of the proband by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed two protein bands with a molecular mass differing by 6% in the vicinity of 28 kDa whereas the HDL particles of the family members exhibited only a single apoA-I band. The largely dominant effect of this mutant allele (designated apoA-ISeattle) on HDL levels suggests that HDL particles containing any number of mutant apoA-I polypeptides are catabolized rapidly.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
R. D. Santos, E. J. Schaefer, B. F. Asztalos, E. Polisecki, J. Wang, R. A. Hegele, L. R. C. Martinez, M. H. Miname, C. E. Rochitte, P. L. Da Luz, et al.
Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency
J. Lipid Res., February 1, 2008; 49(2): 349 - 357.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Bhat, M. Zabalawi, M. C. Willingham, G. S. Shelness, M. J. Thomas, and M. G. Sorci-Thomas
Quality control in the apoA-I secretory pathway: deletion of apoA-I helix 6 leads to the formation of cytosolic phospholipid inclusions
J. Lipid Res., July 1, 2004; 45(7): 1207 - 1220.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. M. Martin-Campos, J. Julve, J. C. Escola, J. Ordonez-Llanos, J. Gomez, J. Binimelis, F. Gonzalez-Sastre, and F. Blanco-Vaca
ApoA-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia
J. Lipid Res., January 1, 2002; 43(1): 115 - 123.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Tailleux, M. Bouly, G. Luc, G. Castro, J.-M. Caillaud, N. Hennuyer, P. Poulain, J.-C. Fruchart, N. Duverger, and C. Fievet
Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice
Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2453 - 2458.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. G. Frank and Y. L. Marcel
Apolipoprotein A-I: structure;-function relationships
J. Lipid Res., June 1, 2000; 41(6): 853 - 872.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. G. Sorci-Thomas, M. Thomas, L. Curtiss, and M. Landrum
Single Repeat Deletion in ApoA-I Blocks Cholesterol Esterification and Results in Rapid Catabolism of Delta 6 and Wild-type ApoA-I in Transgenic Mice
J. Biol. Chem., April 14, 2000; 275(16): 12156 - 12163.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Holvoet, B. De Geest, S. Van Linthout, M. Lox, S. Danloy, K. Raes, and D. Collen
The Arg123-Tyr166 Central Domain of Human ApoAI Is Critical for Lecithin:Cholesterol Acyltransferase-Induced Hyperalphalipoproteinemia and HDL Remodeling in Transgenic Mice
Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 459 - 466.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. M. Hammad, S. Stefansson, W. O. Twal, C. J. Drake, P. Fleming, A. Remaley, H. B. Brewer Jr., and W. S. Argraves
Cubilin, the endocytic receptor for intrinsic factor-vitamin B12 complex, mediates high-density lipoprotein holoparticle endocytosis
PNAS, August 31, 1999; 96(18): 10158 - 10163.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Han, J. Sasaki, A. Matsunaga, H. Hakamata, W. Huang, M. Ageta, T. Taguchi, T. Koga, M. Kugi, S. Horiuchi, et al.
A Novel Mutant, ApoA-I Nichinan (Glu235->0), Is Associated With Low HDL Cholesterol Levels and Decreased Cholesterol Efflux From Cells
Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1447 - 1455.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Matsunaga, J. Sasaki, H. Han, W. Huang, M. Kugi, T. Koga, S. Ichiki, T. Shinkawa, and K. Arakawa
Compound Heterozygosity for an Apolipoprotein A1 Gene Promoter Mutation and a Structural Nonsense Mutation With Apolipoprotein A1 Deficiency
Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 348 - 355.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Miller, D. Aiello, H. Pritchard, G. Friel, and K. Zeller
Apolipoprotein A-IZavalla (Leu159->Pro) : HDL Cholesterol Deficiency in a Kindred Associated With Premature Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1242 - 1247.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. P. Eberhart, A. J. Mendez, and M. W. Freeman
Decreased Cholesterol Efflux from Fibroblasts of a Patient without Tangier Disease, but with Markedly Reduced High Density Lipoprotein Cholesterol Levels
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 836 - 846.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Huang, J. Sasaki, A. Matsunaga, H. Nanimatsu, K. Moriyama, H. Han, M. Kugi, T. Koga, K. Yamaguchi, and K. Arakawa
A Novel Homozygous Missense Mutation in the Apo A-I Gene With Apo A-I Deficiency
Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 389 - 396.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. E. Miettinen, M. Jauhiainen, H. Gylling, S. Ehnholm, A. Palomaki, T. A. Miettinen, and K. Kontula
Apolipoprotein A-IFIN (Leu159->Arg) Mutation Affects Lecithin : Cholesterol Acyltransferase Activation and Subclass Distribution of HDL but Not Cholesterol Efflux From Fibroblasts
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3021 - 3032.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Laccotripe, S. C. Makrides, A. Jonas, and V. I. Zannis
The Carboxyl-terminal Hydrophobic Residues of Apolipoprotein A-I Affect Its Rate of Phospholipid Binding and Its Association with High Density Lipoprotein
J. Biol. Chem., July 11, 1997; 272(28): 17511 - 17522.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. E. Miettinen, H. Gylling, T. A. Miettinen, J. Viikari, L. Paulin, and K. Kontula
Apolipoprotein A-IFin: Dominantly Inherited Hypoalphalipoproteinemia Due to a Single Base Substitution in the Apolipoprotein A-I Gene
Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 83 - 90.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Moriyama, J. Sasaki, Y. Takada, A. Matsunaga, J. Fukui, J. J. Albers, and K. Arakawa
A Cysteine-Containing Truncated Apo A-I Variant Associated With HDL Deficiency
Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1416 - 1423.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. Holvoet, Z. Zhao, E. Deridder, A. Dhoest, and D. Collen
Effects of Deletion of the Carboxyl-terminal Domain of ApoA-I or of Its Substitution with Helices of ApoA-II on in Vitro and in Vivo Lipoprotein Association
J. Biol. Chem., August 9, 1996; 271(32): 19395 - 19401.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. S. Ng, C. Vezina, T. S. Wolever, A. Kuksis, R. A. Hegele, and P. W. Connelly
Apolipoprotein A-I Deficiency : Biochemical and Metabolic Characteristics
Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2157 - 2164.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Marcil, B. Boucher, L. Krimbou, B. C. Solymoss, J. Davignon, J. Frohlich, and J. Genest Jr
Severe Familial HDL Deficiency in French-Canadian Kindreds : Clinical, Biochemical, and Molecular Characterization
Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1015 - 1024.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. H.-J. Schmidt, A. T. Remaley, J. A. Stonik, R. Ronan, A. Wellmann, F. Thomas, L. A. Zech, H. B. Brewer Jr., and J. M. Hoeg
Carboxyl-terminal Domain Truncation Alters Apolipoprotein A-I in Vivo Catabolism
J. Biol. Chem., March 10, 1995; 270(10): 5469 - 5475.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
B. Chait and S. Kent
Weighing naked proteins: practical, high-accuracy mass measurement of peptides and proteins
Science, September 25, 1992; 257(5078): 1885 - 1894.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
D. C. McManus, B. R. Scott, V. Franklin, D. L. Sparks, and Y. L. Marcel
Proteolytic Degradation and Impaired Secretion of an Apolipoprotein A-I Mutant Associated with Dominantly Inherited Hypoalphalipoproteinemia
J. Biol. Chem., June 8, 2001; 276(24): 21292 - 21302.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1991 by the American Society for Biochemistry and Molecular Biology.